Invasive Malignant Neoplasm — Trials

Invasive Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,820 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 604
Recruiting: 302
Ph III recruiting: 36
Growth YoY: +27.2%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (283)

clinicaltrialsPublishedShowing 751–780 of 780 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01194427	A Study of Vorinostat and Tamoxifen in Newly Diagnosed Breast Cancer	terminated	Phase 2	2	Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER	1	May 17, 2013	clinicaltrials
NCT00429182	Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer	completed	Phase 2	32	M.D. Anderson Cancer CenterOTHER	1	Apr 10, 2013	clinicaltrials